CompaniesNeuro Bio

Neuro Bio

active

Oxford, UK

Founded 2013

About

T14 Blocker

Areas of Focus

Categories

DiagnosticsSmall Molecule Pharmaceutical

Team (8)

Baroness Professor Susan Greenfield

Douglas Anderson

Non-Executive Director

View all 8 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

40

By Phase

NA: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT06524284Lead Sponsor

Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation

40 participants

Started: Jul 22, 2024 · Completed: Dec 31, 2024

Funding History (7)

8-K

Aug 10, 2005

8-K/A

Nov 4, 2003

8-K

Jun 9, 2003

8-K

Jan 22, 2003

8-K

Nov 14, 2002

8-K

Oct 2, 2002

8-K

Mar 11, 2002

Locations (1)

Headquarters

Oxford, UK

Map

Loading map...